Cost effective treatment of heparin induced thrombocytopenia
HIT is an important issue in hospital medicine. As I’ve blogged before, when there’s sufficient clinical suspicion early treatment with a direct thrombin inhibitor (without waiting for laboratory confirmation via antibody testing) is indicated to avert severe clinical consequences. Now we also have evidence (via Cardiology in Review) that it’s cost effective. Some good clinical points and references about HIT are found in the article.